Healthcare of Ontario Pension Plan (HOOPP) Trust Fund’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-110,000
Closed -$8.7M 1553
2025
Q4
$8.7M Sell
110,000
-6,000
-5% -$452K 0.01% 510
2025
Q3
$7.59M Hold
116,000
0.01% 492
2025
Q2
$4.58M Buy
+116,000
New +$3.8M 0.01% 526
2024
Q3
Sell
-46
Closed -$2.19K 1097
2024
Q2
$2.19K Buy
+46
New +$1.89K ﹤0.01% 936
2023
Q1
Sell
-63,000
Closed -$2.38M 1371
2022
Q4
$2.38M Sell
63,000
-29,700
-32% -$1.25M 0.01% 682
2022
Q3
$4.1M Buy
+92,700
New +$3.91M 0.02% 453
2022
Q1
Sell
-34,069
Closed -$1.04M 1799
2021
Q4
$1.04M Buy
+34,069
New +$1.07M ﹤0.01% 1140
2021
Q3
Sell
-1,484
Closed -$59K 1831
2021
Q2
$59K Buy
+1,484
New +$58.1K ﹤0.01% 1636

Other funds holding IONS

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund's IONS Position: Q1 2026 in Review

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund sold out of Ionis Pharmaceuticals (IONS) in Q1 2026, closing a stake of 110,000 shares — an estimated $8.7M sold.

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund first reported a position in IONS in Q2 2021 and held it in 8 quarters. The position peaked at $8.7M in Q4 2025. 494 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Healthcare of Ontario Pension Plan (HOOPP) Trust Fund reported no remaining Ionis Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Healthcare of Ontario Pension Plan (HOOPP) Trust Fund sold 110,000 Ionis Pharmaceuticals shares in Q1 2026, an estimated $8.7M.
  • Healthcare of Ontario Pension Plan (HOOPP) Trust Fund first reported a position in Ionis Pharmaceuticals in Q2 2021 and held it in 8 quarters.
  • Healthcare of Ontario Pension Plan (HOOPP) Trust Fund's Ionis Pharmaceuticals position peaked at $8.7M in Q4 2025.
  • 494 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Healthcare of Ontario Pension Plan (HOOPP) Trust Fund's 13F filing for Q1 2026, filed 14 May 2026.